DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Targeting PDK4 to Overcome Rituximab Resistance in DLBCL Jul 17, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma β2M as a Prognostic Marker in DLBCL: NCCN-IPI Integration Jul 12, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma ViPOR Shows Promise in Relapsed DLBCL With Durable Remissions Jul 12, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma VCAN, CD3G, C1QB Influence on DLBCL Prognosis & Drug Sensitivity Jul 10, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Bendamustine: Safe Lymphodepletion Alternative in R/R LBCL Jul 04, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Manufacturing and Efficacy of Axi-Cel in R/R LBCL Jun 19, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma High ORR & Safety of Epcoritamab + Pola-R-CHP in 1L DLBCL Jun 17, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Glofit-GemOx Improves Survival in R/R DLBCL Jun 17, 2024
